224 related articles for article (PubMed ID: 29735160)
1. Genomic insights into Cushing syndrome.
Assié G
Ann Endocrinol (Paris); 2018 Jun; 79(3):119-122. PubMed ID: 29735160
[TBL] [Abstract][Full Text] [Related]
2. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid- and androgen-secreting black adrenocortical adenomas: unique cause of corticotropin-independent Cushing syndrome.
Tanaka S; Tanabe A; Aiba M; Hizuka N; Takano K; Zhang J; Young WF
Endocr Pract; 2011; 17(3):e73-8. PubMed ID: 21700558
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.
Sargent J
Nat Rev Endocrinol; 2014 Jun; 10(6):311. PubMed ID: 24751881
[No Abstract] [Full Text] [Related]
5. Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.
Tatsi C; Stratakis CA
Clin Perinatol; 2018 Mar; 45(1):103-118. PubMed ID: 29406000
[TBL] [Abstract][Full Text] [Related]
6. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
7. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
8. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
9. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
11. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol.
Imai T; Sarkar D; Shibata A; Funahashi H; Morita-Matsuyama T; Kikumori T; Ohmori S; Seo H
Ann Surg; 2001 Jul; 234(1):85-91. PubMed ID: 11420487
[TBL] [Abstract][Full Text] [Related]
12. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
13. Medicine. A unified cause for adrenal Cushing's syndrome.
Kirschner LS
Science; 2014 May; 344(6186):804-5. PubMed ID: 24855241
[No Abstract] [Full Text] [Related]
14. Animal models of adrenocortical tumorigenesis.
Galac S; Wilson DB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):297-310. PubMed ID: 26038202
[TBL] [Abstract][Full Text] [Related]
15. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
Giordano TJ
Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
[No Abstract] [Full Text] [Related]
16. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
17. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
Di Dalmazi G; Altieri B; Scholz C; Sbiera S; Luconi M; Waldman J; Kastelan D; Ceccato F; Chiodini I; Arnaldi G; Riester A; Osswald A; Beuschlein F; Sauer S; Fassnacht M; Appenzeller S; Ronchi CL
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32875319
[TBL] [Abstract][Full Text] [Related]
18. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
19. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
20. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis.
Lekva T; Bollerslev J; Kristo C; Olstad OK; Ueland T; Jemtland R
J Clin Endocrinol Metab; 2010 Jan; 95(1):246-55. PubMed ID: 19875485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
